https://www.selleckchem.com/products/OSI-906.html
nt and prevention of disease progression.Background Benefits of phosphate-lowering interventions on clinical outcomes in patients with chronic kidney disease (CKD) are unclear; systematic reviews have predominantly involved dialysis patients. This study aimed to summarize evidence from randomized controlled trials (RCTs) concerning benefits and risks of non-calcium-based phosphate-lowering treatment in non-dialysis CKD. Methods We conducted a systematic review and meta-analyses of RCTs involving noncalcium-based phosphate-lowering thera
Like
Comment
Share
